SIRIO at Growth Asia Summit 2026: Redefining Oral Beauty with Clinical Evidence

As a well-established global nutraceutical solution provider, SIRIO showcased its latest innovations at Growth Asia Summit 2026 (the "Summit") in Singapore, one of Asia-Pacific's premier gatherings for the nutraceutical industry. Bringing together expertise from its R&D Center and Asia-Pacific Business Unit, SIRIO highlighted its science-driven approach and expanding capabilities in the global nutraceutical market. 

Liang Shanlu, Senior Scientist of Ingredient Innovation at SIRIO, delivered a presentation titled "The Next Breakthrough in Beauty: From Targeted Design to Clinically Visible Results Through Biotransformation". He noted that the dietary supplements market in Asia-Pacific has reached approximately US$76 billion, accounting for nearly half of global demand.

As awareness of collagen continues to grow, consumers are increasingly looking for daily nutrition products that combine an enjoyable experience with scientifically proven benefits. Yet the collagen supplement industry continues to face three major hurdles: limited product differentiation, the lack of a recognized industry gold standard, and inconsistent bioavailability. These challenges make it increasingly difficult for consumers to identify products that deliver meaningful results. SIRIO believes robust clinical evidence is critical to closing this trust gap and substantiating product efficacy.

This evidence-backed approach is embodied in SIRIO's Peptivator® platform. Through targeted biotransformation, the platform creates ultra-small bioactive peptides for enhanced absorption, raising the bar for science-backed innovation in oral beauty. In a 12-week randomized controlled trial, participants showed a 34.2% improvement in skin hydration, a 20.8% increase in elasticity, and a 30.6% reduction in crow's-feet wrinkle volume¹.

Complementing Peptivator®'s focus on enhanced absorption, SIRIO showcased Puracolla™, a collagen gummy developed to deliver a more enjoyable consumer experience. Its innovative "zero added gelling agents" formulation allows collagen itself to serve as the gelling agent in place of conventional gelatin or pectin. With 1,500 mg of collagen per gummy and a sugar-free formulation, Puracolla™ combines a smooth, enjoyable texture with functional benefits without compromising on taste.

Behind SIRIO's science-driven approach to beauty and wellness lies a powerful combination of R&D excellence and a robust global manufacturing network.

With seven production sites across the globe, SIRIO continues to expand its international footprint. Its new industrial park in Chonburi, Thailand, is expected to come online in May 2027, marking another step forward in the Company's "Global for Local" strategy. Combined with robust compliance capabilities spanning TGA, Halal and BPJPH requirements, this global network enables SIRIO to support brands in reaching consumers across markets with greater confidence and efficiency.

Powered by innovation and global reach, SIRIO brings together deep market insight, proprietary technologies, robust clinical evidence and a globally scalable supply network to unlock new growth opportunities across Asia-Pacific and raise the bar for the future of nutraceuticals.

1. Data source: 12-week randomized controlled trial (Chinese Clinical Trial Registry No. ChiCTR2500110378).